The newly published Swedish guidelines for menopausal symptoms are revolutionary – a milestone for women’s health

The Swedish National Board of Health and Welfare has recently published national guidelines for the care of menopausal symptoms (Nationella riktlinjer: klimakteriebesvär - Socialstyrelsen), marking a significant step forward for women’s health – particularly for care provided during and after menopause. For the first time, Sweden now has a unified, evidence-based national framework for the diagnosis, treatment, and follow-up of menopausal symptoms. This is an important tool for healthcare providers and a crucial advancement for women’s right to equitable and respectful care.

Why are the guidelines so important?

For a long time, many women have felt that their symptoms – such as hot flashes, night sweats, sleep disturbances, and mood changes – have not been taken seriously. According to Socialstyrelsen’s own surveys, six out of ten women report moderate to severe symptoms during menopause, and one in three were unprepared for the onset of symptoms. At the same time, access to treatment and the quality of care vary greatly across the country. In some regions, hormone therapy is prescribed much more frequently than in others, and many women are referred on without receiving proper support or advice in primary care. These variations reflect a lack of structure, coordination, and equality: women of the same age and with the same symptoms may not receive the same care depending on where in the country they live.

What do the guidelines mean?

The new guidelines include several key components:

• A national standard: The entire healthcare chain, from primary to specialist care, should follow the same evidence-based recommendations. Previously, there was no unified framework for how menopause and related symptoms should be managed in Swedish healthcare. Now, all regions are expected to follow the same guidelines.
• A stronger role for primary care: Health centres, midwifery clinics, and general practitioners are expected to play a greater role in identifying, treating, and following up menopausal symptoms. Previously, many women were referred onward without active involvement from primary care.
• Patient-centred dialogue and choice: Symptoms and quality of life should be assessed in dialogue between the woman and the healthcare provider. Treatment – including menopausal hormone therapy (MHT) or alternative options – should be based on individual benefit versus risk, and on the woman’s own preferences.
• Follow-up and indicators: To ensure that the guidelines are not merely “fine words” but are actually implemented, indicators will be introduced to monitor and evaluate how the care functions in practice.Equitable care without regional disparities: The guidelines explicitly aim to reduce regional inequalities and ensure that all women – regardless of where they live – can access evidence-based care.

What this means for you as an individual woman

You can expect your symptoms to be taken more seriously, with improved access to information, support, and advice. Your local health centre can serve as a genuine first point of contact for menopause-related concerns, rather than immediately referring you elsewhere. If you live in a region where menopause care has previously been weak, you may now have a better chance of receiving new or improved support as the guidelines are implemented. You will have greater opportunity to take part in care decisions – together with your provider, weighing the risks and benefits of different treatment options.

Implementation is key

This is a milestone – but it is also a beginning. Developing guidelines is only the first step. The real challenge lies in implementation: ensuring that all health centres, gynaecology clinics, and midwifery practices adopt the new routines, receive training, resources, and support to make real changes. If these guidelines are effectively implemented, they could fundamentally reshape how menopause is viewed – from a “natural but silent” stage of life to a recognised area of healthcare where women’s voices are heard and care is defined by respect and equality.

The situation in Norway, Denmark, and England

Norway: In Norway, guidelines exist in sources such as the Norwegian Electronic Medical Handbook and the national gynaecology society. A Nordic overview notes that Norwegian guidance mainly focuses on hormone therapy and that there is a need for broader, more holistic national guidelines. There is still no comprehensive national framework equivalent to Sweden’s, with clear indicators and an equality focus across the entire care chain.

Denmark: Denmark, like several other Nordic countries, does not yet have equally developed guidelines for menopause within primary care. Current reviews highlight knowledge gaps and a need for better coordination. This means that many Danish women may still experience menopause care as fragmented and inconsistent.

England: In England, the National Institute for Health and Care Excellence (NICE) has recently updated its guidelines, “Menopause: Identification and Management” (NG23). These recognise that hormone therapy should often be considered early and that care must be individualised. There is also increasing attention to the impact of menopause on women in the workplace and to creating “menopause-friendly” work environments. England can therefore be seen as a pioneer in bringing menopause into public focus, though challenges remain in ensuring consistent implementation.

For women living in any of these countries, the new Swedish guidelines make it easier to compare approaches and perhaps create new expectations or demands for care locally. When contacting your healthcare provider, you can ask which guidelines are followed and whether they are as comprehensive and evidence-based as Sweden’s. If you feel that menopause care in your country is lacking, this is a good moment to raise the issue – as there is a growing international movement to recognise menopause as a legitimate and important area of women’s healthcare. You should feel confident that your symptoms are not something you simply have to “put up with”, but part of a broader commitment to improving women’s health and quality of life everywhere.

Summary

The new Swedish guidelines for menopause care represent a major step forward for women’s health and for equitable healthcare. By clarifying responsibilities, setting standards, and promoting dialogue between women and healthcare providers, they lay the foundation for better support and treatment. At the same time, comparisons with Norway, Denmark, and England show that while progress is being made elsewhere, gaps and opportunities remain – both within healthcare systems and for women themselves to claim the care they deserve.

So – take space, ask questions, and demand that your symptoms and your quality of life are taken seriously.

Love YourSelf 🤍 Love Your V